Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06047028 · ClinicalTrials.gov registry record

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

A clinical trial of Coronary Artery Disease and Ischemic Heart Disease (IHD), sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT06047028 is a study of Coronary Artery Disease and Ischemic Heart Disease (IHD) that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 30 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06047028, a study of Coronary Artery Disease and Ischemic Heart Disease (IHD), is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Heart failure due to coronary artery disease represents a significant cause of mortality. The detection of patients eligible for bypass surgery is a pivotal concern. Nevertheless, the optimal approach for patient selection based on conventional imaging scans remains unclear. The proposed method (Hyperpolarized 13C MRI) has gained extensive use in evaluating in vivo metabolism. This method avoids ionizing radiation and provides critical insights into cardiac function. The feasibility study aims to investigate this method for patient selection before bypass surgery. This innovative imaging technique facilitates the identification of two simple molecules, bicarbonate and lactic acid, produced at high rates by normal heart metabolism. Both bicarbonate and lactate originate from the same precursor molecule, pyruvate. The data generated from this study holds the potential to refine diagnostic precision.

Conditions Studied

Coronary Artery Disease Ischemic Heart Disease (IHD) Myocardial Viability

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-06-30
Est. Completion 2026-06-30

Sponsor

University of Texas Southwestern Medical Center

837 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06047028

The ClinicalTrials.gov registry entry for NCT06047028 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT06047028 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06047028 about?

NCT06047028 is a clinical study titled "Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability". Heart failure due to coronary artery disease represents a significant cause of mortality. The detection of patients eligible for bypass surgery is a pivotal concern. Nevertheless, the optimal approach for patient selection based on conventional imaging scans remains unclear. The proposed method (Hyp...

What is the current status of trial NCT06047028?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2023-06-30. Estimated completion is 2026-06-30.

What conditions does trial NCT06047028 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Ischemic Heart Disease (IHD), Myocardial Viability.

Who is sponsoring clinical trial NCT06047028?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06047028 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Ischemic Heart Disease (IHD)

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.